GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inhibrx Biosciences Inc (NAS:INBX) » Definitions » PB Ratio

INBX (Inhibrx Biosciences) PB Ratio : 1.23 (As of Dec. 12, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Inhibrx Biosciences PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-12), Inhibrx Biosciences's share price is $15.12. Inhibrx Biosciences's Book Value per Share for the quarter that ended in Sep. 2024 was $12.33. Hence, Inhibrx Biosciences's PB Ratio of today is 1.23.

The historical rank and industry rank for Inhibrx Biosciences's PB Ratio or its related term are showing as below:

INBX' s PB Ratio Range Over the Past 10 Years
Min: 0.73   Med: 1.08   Max: 1.31
Current: 1.21

During the past 2 years, Inhibrx Biosciences's highest PB Ratio was 1.31. The lowest was 0.73. And the median was 1.08.

INBX's PB Ratio is ranked better than
76.15% of 1279 companies
in the Biotechnology industry
Industry Median: 2.54 vs INBX: 1.21

Back to Basics: PB Ratio


Inhibrx Biosciences PB Ratio Historical Data

The historical data trend for Inhibrx Biosciences's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inhibrx Biosciences PB Ratio Chart

Inhibrx Biosciences Annual Data
Trend Dec22 Dec23
PB Ratio
- -

Inhibrx Biosciences Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial - - - 0.94 1.27

Competitive Comparison of Inhibrx Biosciences's PB Ratio

For the Biotechnology subindustry, Inhibrx Biosciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inhibrx Biosciences's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Inhibrx Biosciences's PB Ratio distribution charts can be found below:

* The bar in red indicates where Inhibrx Biosciences's PB Ratio falls into.



Inhibrx Biosciences PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Inhibrx Biosciences's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=15.12/12.329
=1.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Inhibrx Biosciences  (NAS:INBX) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Inhibrx Biosciences PB Ratio Related Terms

Thank you for viewing the detailed overview of Inhibrx Biosciences's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Inhibrx Biosciences Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11025 N. Torrey Pines Road, Suite 140, La Jolla, CA, USA, 92037
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.